Change in antibiotic resistance of group B Streptococcus: Impact on intrapartum management

American Journal of Obstetrics and Gynecology

Volumn 181, Issue 2, 1999, Pages 310-314

  Morales, Walter J ^a,b   Dickey, Sonja S ^a   Bornick, Patricia ^a   Lim, Daniel V ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b Florida Perinatal Associates   (United States)

Author keywords

Antibiotic resistance; Centers for Disease Control and Prevention protocol; Group B Streptococcus

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CLINDAMYCIN; ERYTHROMYCIN; PENICILLIN G;

ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BACTERIUM ISOLATION; CHEMOPROPHYLAXIS; CLINICAL PROTOCOL; CONFERENCE PAPER; FEMALE; HUMAN; NEWBORN SEPSIS; PENICILLIN ALLERGY; PRIORITY JOURNAL; STRAIN DIFFERENCE; STREPTOCOCCUS AGALACTIAE; TREATMENT PLANNING;

EID: 0032870087     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(99)70553-3     Document Type: Conference Paper

References (14)

1. 1. Zangwill KM, Schuchat A, Wenger JD. Group B streptococcal disease in the United States, 1990; report from a multistate active surveillance system. MMWR Morb Mortal Wkly Rep 1992;41:25-32.
2. 2. Baker CJ, Edward MS. Group B streptococcal infections. In: Remington JS, KJein JO, editors. Infectious diseases of the fetus and newborn infant. 4th ed. Philadelphia: WB Saunders; 1995. p. 980-1054.
3. 3. American College of Obstetricians and Gynecologists. Group B streptococcal infections in pregnancy. Washington: ACOG; 1992. ACOG Technical Bulletin No.: 170.
4. 4. Yow MD, Mason EO, Leeds LJ. Thompson PK, Clark DJ, Gardner SE. Ampicillin prevents intrapartum transmission of group B streptococcus. JAMA 1979;241:1245-7.
5. 5. Lim DV, Morales WJ, Walsh AF, Kazanis D. Reduction of morbidity and mortality rates of neonatal group B streptococcal disease through early diagnosis and chemoprophylaxis. J Clin Microbiol 1986;23:489-92.
6. 6. Boyer KM, Gotoff SP. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med 1986;314:1665-9.
7. 7. Schuchat A, Whitney C, Zangwill K. Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR Morb Mortal Wkly Rep 1996;45:1-24.
8. 8. Berkowitz K, Regan JA, Greenberg E. Antibiotic resistance patterns of group B streptococci in pregnant women. J Clin Microbiol 1989;28:5-7.
9. 9. Fernandez M, Hickman MF., Baker C.J. Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with barteremia or meningitis. Antimicrob Agents Chemother 1998;42:1517-9.
10. 10. Pearlman MD, Pierson CL, Faix RG. Frequent resistance of clinical group B streptococci isolates to clindamycin and erythromycin. Obstet Gynecol 1998;92:258-61.
11. 11. Siegel JC, McCracken GH, Threlkeld N. Single-dose penicillin prophylaxis of neonatal group B streptococcal disease: conclusion of a 41 month controlled trial. Lancet 1982;1:1426-30.
12. 12. Pyati SP, Rosita S, Pildes MD. Penicillin on infants weighing two kilograms or less with early onset group B streptococcal disease. N Engl J Med 1983;308:1838-9.
13. 13. Morales WJ, Lim DV, Walsh AF. Prevention of neonatal group B streptococcal sepsis by the use of a rapid screening test and selective intrapartum chemoprophylaxis. Am J Obstet Gynecol 1986;155:979-83.
14. 14. McDuffie RS, McGregor JA, Gibbs RS. Adverse perinatal outcome and resistant enterobacteriacease after antibiotic usage for premature rupture of membranes and group B streptococcus carriage. Obstet Gynecol 1993;82:487-9.